Tag: AKBA

Upside

– $SEZL +30% (Q3 revenue and transaction volume surged, FY guidance was raised for the fourth time and preliminary 2027 EPS guidance was introduced)
– $ARQ +26% (record Q3 revenue, sharp margin expansion and the low end of FY EBITDA guidance was raised)
– $APP +22% (Q3 profit beat and revenue came in $100 million above the top of the company’s forecast)
– $RUN +21% (Q3 beat as direct installations returned to growth and storage attachment reached a record)
– $WRBY +21% (raised the low end of FY sales guidance and confirmed November 12 preorders for its first Intelligent Eyewear collection)
– $ADMA +20% (ASCENIV sales rose 31%, gross margin expanded sharply and the adjusted earnings outlook was raised)
– $U +20% (strongest quarter on record, with Vector revenue up 126% and the first GAAP profit since its IPO)
– $TPR +14% (Q1 beat with strong Coach growth and FY revenue, margin and EPS guidance raised)
– $EPAM +12% (Q3 beat alongside a $1.5 billion buyback expansion and planned $500 million accelerated repurchase)
– $TM +8.8% (first-half profit strengthened and the full-year operating-income and net-income forecasts were raised)
– $SONY +6.0% (Q2 profit surged on gaming and film strength, prompting higher full-year sales, profit and dividend forecasts)
– $BABA +5.3%, $TCOM +4.3%, $NTES +3.9%, $PDD +3.7%, $JD +4.2% (China ADRs rise with an overnight rebound in Hong Kong technology shares)
– $GFI +4.4% (gold producer gains as bullion prices rally)
– $CELH +2.7% (record Q3 revenue rose 17% as the expanded beverage portfolio sustained growth)
– $UBER +2.4% (Amazon Prime members can now order Uber Eats with free delivery on qualifying purchases)

Downside

– $MNTN -46% (slashed FY revenue and EBITDA guidance after sales-team execution problems and named a new CEO)
– $BZFD -34% (Q3 revenue plunged 44%, adjusted EBITDA turned negative and the FY outlook was deferred)
– $VCYT -32% (lowered near-term Decipher Prostate expectations, narrowed FY guidance below consensus and forecast only mid-single-digit 2027 revenue growth)
– $ANVS -29% (proposed a dilutive stock-and-warrant offering while disclosing limited cash, going-concern risk and expanded authorized shares)
– $AKBA -25% (Q3 revenue fell sharply as Auryxia sales were hit by generic competition and pricing pressure)
– $HIMX -25% (guided Q4 revenue down 22% to 26% sequentially on abrupt automotive-display order corrections)
– $GIL -23% (Q3 missed expectations, FY sales and EPS guidance was cut sharply and 2026–2028 objectives were withdrawn)
– $WMS -13% (organic stormwater sales declined, demand softened and the FY revenue outlook was reduced)
– $QCOM -11% (smartphone-chip sales missed expectations on sluggish demand and declining Apple-related revenue)
– $FICO -10% (withheld FY27 guidance amid mortgage-pricing uncertainty and was downgraded by RBC despite a quarterly beat)
– $SNAP -10% (Q3 revenue missed expectations)
– $MELI -9.2% (earnings missed and logistics investment compressed operating margin despite strong revenue growth)
– $AMCR -8.1% (profit missed and the six-month EPS outlook was cut as energy and distribution costs outpaced pricing recovery)
– $ASX -7.6%, $SNDK -5.8%, $SKHY -6.2%, $STX -4.5% (Asian and memory-chip names extend the semiconductor selloff as election results intensify concerns over slower data-center construction)
– $ARM -7.4% (quarter beat, but current-quarter guidance failed to clear elevated expectations and shares joined the broader chip selloff)
– $HUBS -6.5% (Q3 beat, but Q4 profit guidance came in below expectations)
– $BDX -5.4% (Q4 beat, but low-single-digit FY27 revenue growth and modest EPS growth guidance disappointed)